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Hutchinson-Gilford progeria syndrome (HGPS) is a
premature aging disease caused by a truncated
lamin A protein (progerin) that drives cellular and
organismal decline. HGPS patient-derived fibro-
blasts accumulate genomic instability, but its un-
derlying mechanisms and contribution to disease
remain poorly understood. Here, we show that pro-
gerin-induced replication stress (RS) drives genomic
instability by eliciting replication fork (RF) stalling and
nuclease-mediated degradation. Rampant RS is
accompanied by upregulation of the cGAS/STING
cytosolic DNA sensing pathway and activation of
a robust STAT1-regulated interferon (IFN)-like
response. Reducing RS and the IFN-like response,
especially with calcitriol, improves the fitness of
progeria cells and increases the efficiency of cellular
reprogramming. Importantly, other compounds that
improve HGPS phenotypes reduce RS and the
IFN-like response. Our study reveals mechanisms
underlying progerin toxicity, including RS-induced
genomic instability and activation of IFN-like re-
sponses, and their relevance for cellular decline in
HGPS.
INTRODUCTION
A-type lamins (lamin A/C), nuclear structural components, pro-
vide a scaffold for the compartmentalization of genome function
(van Steensel and Belmont, 2017). LMNA gene mutations are
associated with degenerative disorders termed laminopathies,
including Hutchinson-Gilford progeria syndrome (HGPS), a pre-
mature aging disease that causes patients death in their teens
from cardiovascular disease (CVD) (Gordon et al., 2014; Pereira
et al., 2008). Since HGPS was genetically mapped, we have
made major strides understanding its pathology and identified
therapies that ameliorate disease in mouse models (Gonzalo
et al., 2016). However, we still lack strategies to ameliorate dis-
ease progression in patients, because of the extensive toxic ef-
fects of progerin, including disruption of nuclear architecture,
and genome stability and function. The current view is that key
mechanisms behind progerin-induced cellular and organismal
aging remain to be discovered.
Extensive evidence links progerin expression with DNA repair
deficiencies and telomere dysfunction (Cao et al., 2011a; Choj-
nowski et al., 2015; Gonzalo and Kreienkamp, 2015). Although
replication stress (RS) is a major contributor to genomic insta-
bility, having serious implications for cell survival and human dis-
ease, how progerin affects DNA replication has been minimally
explored. Studies suggest that lamins are required for restart
of stalled replication forks (RFs) (Singh et al., 2013) and that
progerin disrupts PCNA/lamin A interactions by sequestering
PCNA away from the RF (Cobb et al., 2016; Hilton et al., 2017;
Wheaton et al., 2017). However, the mechanisms whereby pro-
gerin causes RS and the consequences for progeria cellular
fitness remain unknown.
The concept is emerging that DNA damage and RS not only
underlie the genomic instability that drives aging and cancer
but also contribute to activate inflammatory responses that facil-
itate malignancy in some cases and senescence in others
(Brzostek-Racine et al., 2011; Ha¨rtlova et al., 2015; Yu et al.,
2015). For instance, RS leads to accumulation of self-nucleic
acids in the cytoplasm that are erroneously recognized as
foreign by pattern recognition receptors (PRRs), proteins that
survey the extracellular and cytoplasmic space for the presence
of pathogens, activating immune responses (Ahn et al., 2014;
Bhattacharya et al., 2017; Wolf et al., 2016). In particular, the
cGAS/STING cytosolic DNA sensing pathway is critical for acti-
vating interferon (IFN) responses (Vincent et al., 2017) and has
been implicated in neoplasia (Mackenzie et al., 2017; Wang
et al., 2017) and senescence (Yang et al., 2017).
Here, we show that progerin elicits RF stalling and nuclease-
mediated fork degradation, revealing a mechanism underlying
DNA damage accumulation in HGPS. RS is accompanied by
upregulation of the cGAS/STING pathway and activation of a
robust STAT1-regulated IFN-like response. Moreover, we
demonstrate that reduction of RS and the IFN-like response
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improves HGPS cellular fitness, suggesting a role for these path-
ways in progerin-induced pathology.
RESULTS
Progerin Expression Causes RF Stalling and
Degradation
To determine how progerin affects DNA replication, we per-
formed single-molecule replication analysis (DNA fiber assays)
in retinal pigment epithelial (RPE) cells lentivirally transduced
with progerin or empty vector (EV) (Figure 1A). We labeled repli-
cation events with the thymidine analogs iododeoxyuridine (IdU)
and chlorodeoxyuridine (CldU), measured individual IdU and
CldU tract lengths, and calculated the CldU/IdU ratio. In control
cells (EV), the CldU/IdU ratio is 1, consistent with normal RF
progression. Progerin expression causes shortening of CldU
tract length and thus decreased CldU/IdU ratio (Figure 1A), as
well as increased frequency of stalled forks (Figure 1B). Impor-
tantly, overexpression of lamin A protein did not cause repli-
cation defects (Figure 1C). To determine if tract shortening
upon progerin expression is due to fork deprotection and
nuclease-mediated degradation, we treated cells with mirin, an
inhibitor of MRE11 nuclease that attacks deprotected stalled
forks (Schlacher et al., 2011). Mirin rescues replication problems
(Figure 1D), indicating that progerin causes fork deprotection
and degradation. Thus, we demonstrate that progerin perturbs
fork progression, causing RS. Given our findings that calcitriol
reduces DNA damage in HGPS cells (Kreienkamp et al., 2016),
we tested if it ameliorates RS in progerin-expressing cells. We
find that the reduced ratio CldU/IdU in progerin-expressing cells
is normalized by calcitriol (Figure 1E). This indicates that calcitriol
rescues RS, providing a mechanism behind the effects of calci-
triol ameliorating DNA damage in HGPS cells. Accordingly,
HGPS fibroblasts show high levels of phosphorylated RPA
(P-RPA), a marker of single-stranded DNA (ssDNA) associated
with RS andDNAdamage (Murphy et al., 2014), which is reduced
by calcitriol (Figure 1F).
Activation of an IFN-like Response in HGPS Cells
DNA damage and RS can activate IFN responses, which in turn
can contribute to senescence or malignant transformation (Ha¨r-
tlova et al., 2015; Yu et al., 2015). Interestingly, our genome-wide
expression analysis of HGPS cells reveals robust activation of a
STAT1-mediated IFN-like response and a marked repression of
this response by calcitriol. Figure 2 shows the results of RNA
sequencing (RNA-seq) performed in HGPS fibroblasts derived
from four patients, and normal fibroblasts (NFs) from three par-
ents, subjected to prolonged (3 months) and short (4 days) treat-
mentswith calcitriol or vehicle (Figure 2A). Differential expression
was tested between HGPS/NF and HGPScalcitriol/vehicle (short
and long treatment combined), and pathway analysis was per-
formed using DAVID and STRING with genes showing a fold
change (FC) > 1.5 or < 0.6 and p % 0.05. Figure 2B shows the
main changes in biological processes in the different conditions.
Note the upregulation of genes in the IFN/antiviral/innate
immunity category in HGPS cells and how calcitriol treatment
downregulates genes in this category. Calcitriol also counteracts
deregulation of other biological processes, such as extracellular
matrix/cell adhesion and the Wnt/b-catenin pathway, previously
identified in progerin-expressing cells (Csoka et al., 2004;
Scaffidi and Misteli, 2008). A more complete analysis of gene
expression changes in NFs and HGPS cells treated with vehicle
or calcitriol is shown in Table S1. The heatmap in Figure 2C
focuses on the most robust signature, the IFN/antiviral/innate
immunity process, with nearly 50 genes in this pathway upregu-
lated in HGPS and downregulated by calcitriol. These include
genes encoding for PRRs (RIG-I, MDA5, OASs, and TLR3),
PRR effectors (MYD88, IRF1/7/9, STAT1, and NFkB), and more
than 40 STAT1-regulated IFN-stimulated genes (ISGs). This
signature represents a robust IFN-like response. However,
IFNs themselves are not expressed in HGPS fibroblasts, indi-
cating that the upregulation of STAT1 and ISGs is a cell-intrinsic
and IFN-independent process. In addition, calcitriol reduces
expression of the majority of genes in the PRR/STAT1/IFN-like
response that are upregulated in HGPS cells, indicating a robust
effect suppressing this pathway.
STAT1-mediated regulation of ISGs contributes to inflam-
mation, especially during atherosclerosis, being an important
therapeutic target for CVD (Szelag et al., 2016). STAT1 is acti-
vated by phosphorylation on Y701, which promotes its translo-
cation to the nucleus, where it is further phosphorylated on
S727, resulting in maximal transcriptional regulation of target
genes. This is part of the innate immune response that activates
ISGs. Immunofluorescence analysis shows that STAT1 is found
in the cytoplasm and the nucleus inNFs, as expected (Figure 2D).
HGPS cells show accumulation of STAT1 and P-STAT1Y701 in
the nucleus, suggesting constitutive STAT1 activation. Impor-
tantly, STAT1 is phosphorylated in early passage HGPS cells,
and 4-day calcitriol treatment reduces its phosphorylation (Fig-
ures 2E and 2G). Subcellular fractionation shows increased
levels of nuclear P-STAT1Y701 and IRF3 in HGPS cells, which
are reduced by calcitriol (Figures 2F and 2G). These data show
that HGPS cells activate PRRs and STAT1 and that calcitriol
counteracts their activation.
Progerin Expression Activates the cGAS/STING
Cytosolic DNA Sensing Pathway and STAT1-Regulated
IFN-like Response
To determine if progerin expression is sufficient to activate the
STAT1-mediated IFN-like response in normal cells, we trans-
duced BJ fibroblasts with progerin or EV control. As shown in
Figures 3A and S1, progerin expression increases markers of
DNA damage (gH2AX) and RS (P-RPA), global levels of PRRs,
including cGAS and STING (DNA sensors), and RIG-I and
OAS1 (RNA sensors), in addition to STAT1 and IRF3. As evidence
for the role of STAT1 mediating upregulation of ISGs, reduced
expression of STAT1 in HGPS cells with different short hairpin
RNAs (shRNAs) reduces expression of MX1, APOBEC3G, and
IFIT1 (Figure 3B), which are among the most highly upregulated
ISGs in HGPS cells. These data demonstrate that progerin acti-
vates the cGAS/STING pathway and a STAT1-modulated IFN-
like response. To monitor the activation of these pathways
upon progerin expression over time, we used human
skin-derived fibroblasts (HDF) containing GFP-progerin or
GFP-lamin A under the control of doxycycline-inducible (Tet-on)
promoters (Figure 3C). Expression of GFP-progerin in these cells
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Figure 1. Replication Stress (RS) in Progerin-Expressing Cells
(A) RPE cells were lentivirally transduced with progerin or empty vector (EV), and single-molecule replication analysis was performed. Immunoblots show the
expression levels of progerin. Images show the incorporation of thymidine analogs in cells labeled with IdU for 25 min + CldU for 25 min, as detected by
fluorescence confocal microscopy. Tract lengths are measured using ImageJ. Graph shows the tract length ratio CldU/IdU, which in control cells is 1 and in
progerin-expressing cells is lower, indicating RF progression defects. Each experiment represents a biological repeat, with independent progerin expression. In
each experiment, 200–250 forks were measured.
(B) The frequencies of stalled forks (only IdU signal) and progressing forks (both IdU and CldU signals) were counted in the three independent experiments in (A).
(C) DNA fibers were performed in RPE cells transduced with lamin A, progerin, or EV constructs. Graph shows the average ratio CldU/IdU in three biological
repeats.
(D) DNA fiber assays performed with the same labeling scheme as in (A) in progerin-expressing and control RPE cells and treated with vehicle or mirin (5 mM) for
3 hr to inhibit Mre11 nuclease.
(E) Progerin-expressing and control RPE cells were treated with calcitriol (100 nM) for 10 days, and DNA fiber assays were performed as in (A).
(F) Untreated NFs and HGPS fibroblasts treated with vehicle or calcitriol for 4 days were processed for immunoblotting to monitor the levels of phosphorylated
RPA (P-RPA) and H2AX (gH2AX). Vinculin was used as loading control.
* denotes p value of statistical significance (*p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001). Error bars represent SEM.
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Figure 2. An IFN-like Response in HGPS Fibroblasts is Repressed by Calcitriol
(A) Scheme of the samples analyzed by RNA-seq. NFs derived from three parents of HGPS patients were sequenced. One line of NFs was supplemented with
calcitriol (100 nM) or vehicle for 4 days in three biological repeats. HGPS fibroblasts derived from four patients were subjected to prolonged (3 months) and short
(4 days) treatments with calcitriol or vehicle. RNA was extracted and sequenced.
(legend continued on next page)
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causes nuclear defects, decreased lamin B1 and LAP2 levels,
reduced heterochromatic marks, and DNA damage accumula-
tion (Kubben et al., 2016). We find upregulation of cytosolic sen-
sors of DNA (cGAS and STING) and RNA (RIG-I and MDA5), and
increased STAT1 phosphorylation 4 days post-induction of
GFP-progerin (Figure 3C). In contrast, expression of GFP-lamin
A does not upregulate any of these factors (Figure 3C). In addi-
tion, progerin elicits upregulation of ISG15, a ubiquitin-like small
protein that modifies covalently proteins (ISGylation) upon IFN
pathway activation. The upregulation of ISGs (MX1, IFIT3, and
ISG15) upon progerin induction was confirmed at the transcript
level (Figure 3D). Thus, progerin expression rapidly activates
an IFN-like response. Moreover, immortalized adult fibroblasts
from a mouse model of HGPS (LmnaG609G/G609G iMAFs) show
nuclear accumulation of P-STAT1 (Figure 3E) and increased
global levels of gH2AX, P-STAT1, and PRRs (Figure 3F), thus
indicating activation of STAT1/IFN signaling also in progerin-
expressing mouse cells. Interestingly, progerin-expressing hu-
man and mouse cells accumulate difficult-to-replicate domains
such as telomeric DNA in the cytoplasm, as shown by im-
muno-fluorescence in situ hybridization (FISH) performed with
lamin A antibody and a PNA-labeled telomere probe (Figure 3G).
These data support the notion that cytoplasmic accumulation of
nucleic acids due to RS and DNA damage triggers STAT1 activa-
tion and an IFN-like response in progerin-expressing cells.
Activation of STAT1-Mediated IFN-like Response
Contributes to Progeria Cellular Phenotypes
We postulated that if the pathways identified here contribute
to progerin cellular toxicity, treatments known to ameliorate
HGPS cellular phenotypes might repress these pathways. These
treatments include rapamycin, which increases progerin clear-
ance by autophagy (Cao et al., 2011b); lonafarnib, which inhibits
prenylation of progerin (Gordon et al., 2016); retinoids such as
ATRA, which repress progerin expression (Kubben et al., 2015;
Pellegrini et al., 2015; Swift et al., 2013); and remodelin (Larrieu
et al., 2014). We tested how these compounds affect DNA
replication and STAT1 activation. Progerin-expressing RPE cells
and HGPS fibroblasts were treated with vehicle, calcitriol,
ATRA, remodelin, or a combination of lonafarnib and rapamycin
for 10 days, as this combination is being tested in a clinical trial
for HGPS (Collins, 2016). Interestingly, all these treatments
rescue replication problems, as shown by DNA fiber assays
(Figure 4A), and reduce the levels of active phosphorylated
STAT1 (Figure 4B), although to different extents. Thus, strategies
that ameliorate HGPS cellular phenotypes mimic the effect of
calcitriol, reducing RS and repressing the STAT1 pathway,
though calcitriol’s effect is the most robust. Our data suggest
that RS and the STAT1/IFN-like response contribute to the
decline of HGPS cells. Supporting this notion, the STAT1/IFN
pathway is activated in aged normal human fibroblasts and
associated with their decreased functionality (proliferation,
migration, and differentiation) (Midgley et al., 2016). We gener-
ated progerin-expressing fibroblasts knocked down for STAT1
(Figure 4C) and characterized their functionality. We identified
shRNAs that when transduced in progerin-expressing cells
reduce STAT1 to near normal levels (Figure 4C). STAT1-knock-
down (KD) reduces progerin-induced upregulation of RIG-I,
STING, and ISG15 (both conjugated and free), as expression of
these factors is regulated by STAT1. Consistent with STAT1
anti-proliferative effects in NFs, STAT1-KD increases prolifera-
tion in control cells (Figure 4D). Importantly, STAT1-KD restores
normal proliferation of progerin-expressing cells, as shown by
Ki67 positivity (Figure 4D) and normal migration in a wound
closure assay (Figure 4E). These data demonstrate that the
STAT1/IFN response contributes to functionality decline of pro-
gerin-expressing fibroblasts and suggest that the beneficial ef-
fects of calcitriol and other compounds improving HGPS cellular
aging phenotypes involve repression of this response.
Hallmarks of aging in HGPS fibroblasts include genomic insta-
bility, premature senescence, and low efficiency of reprogram-
ming into induced pluripotent stem cells (iPSCs) (Liu et al.,
2011; Zhang et al., 2011). Reprogramming of somatic cells into
iPSCs erases phenotypic hallmarks of aging, being a paradigm
of rejuvenation. There is evidence for RS and inflammatory re-
sponses being barriers to efficient reprogramming (Ruiz et al.,
2015; Soria-Valles et al., 2015). Given that calcitriol improves
RS and aging phenotypes in HGPS cells, we tested its effect
on reprogramming. HGPS fibroblasts were treated with calcitriol
for 7 days and transduced with the ‘‘Yamanaka’’ factor cocktail
OSKM (Oct4/Sox2/Klf4/Myc). We found that calcitriol increased
significantly the efficiency of reprogramming into iPSCs
compared with untreated cells (Figure 4F). This indicates that
calcitriol ‘‘rejuvenates’’ HGPS cells and that amelioration of RS
and repression of the STAT1/IFN-like response might contribute
to its rejuvenating effect.
DISCUSSION
Our study shows that progerin expression causes RF stalling and
nuclease-mediated degradation of the stalled forks. Given that
DNA replication is the major source of spontaneous DNA dou-
ble-strand breaks in dividing cells (Berti and Vindigni, 2016), pro-
gerin-induced RS could be a major cause of DNA damage in
(B) Heatmap shows the Gene Ontology (GO) analysis performed with the differential gene expression analysis (FC > 1.5 and < 0.6 and p % 0.05) between
HGPS/NF and HGPScalcitriol/vehicle using DAVID and STRING.
(C) Heatmap shows differential expression (upregulation) of 50 genes in the IFN/antiviral/innate immunity pathway between HGPS/NF and a decrease in
HGPScalcitriol/vehicle.
(D) NF and HGPS fibroblasts were processed for immunofluorescence with antibodies recognizing STAT1 and active P-STAT1Y701 and nuclei stained with DAPI.
(E) Total cell lysates from untreated NFs and HGPS fibroblasts treated with vehicle or calcitriol for 4 days were processed for immunoblotting to monitor global
levels of progerin, STAT1, and P-STAT1Y701. b-Tubulin was used as loading control.
(F) Untreated NFs and HGPS cells treated with calcitriol or vehicle for 4 days were subjected to subcellular fractionation to monitor localization of P-STAT1Y701
and IRFs. Note the nuclear accumulation of P-STAT1 and IRF3 in HGPS cells and how calcitriol reduces their nuclear levels (red square).
(G) Graph shows mean densitometry analysis (a.u.) of immunoblots from (E) and (F).
* denotes p value of statistical significance (*p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001). Error bars represent SEM.
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HGPS cells. RS is accompanied by the activation of a robust
cell-intrinsic IFN-like response regulated by STAT1, which con-
tributes to cellular decline in progeria. As such, compounds
known to improve HGPS cell phenotypes, especially calcitriol,
rescue RS, repress the STAT1/IFN-like response, and increase
efficiency of reprogramming of HGPS cells, a paradigm of reju-
venation. Our study reveals molecular mechanisms underlying
progerin toxicity and evidence for the broad benefits of calcitriol
ameliorating aging phenotypes, suggesting that its use in pre-
clinical models of progeria should be investigated.
IFN/inflammatory responses are activated in other syn-
dromes of genomic instability and accelerated aging, such as
ataxia telangiectasia (AT) and Fanconi anemia (FA) (Bre´gnard
et al., 2016; Ha¨rtlova et al., 2015), and in telomerase KO mice
(Yu et al., 2015). However, we find a fundamental difference be-
tween the activation of this pathway in HGPS and other syn-
dromes, namely, the lack of expression of IFNs themselves.
This suggests that the STAT1-mediated IFN-like response iden-
tified in HGPS is activated via cell-intrinsic non-canonical path-
ways that are independent of IFNs. IFN-independent activation
of STAT1 by p38-MAPK, RIG-I, and Toll-like receptors (TLRs)
has been reported in response to different stresses (Dempoya
et al., 2012; Luu et al., 2014). These pathways could contribute
to STAT1 activation in HGPS cells. Our results are consistent
with studies monitoring markers of inflammation in urine and
plasma samples from HGPS patients, which do not show
increased levels of IFNs or a robust upregulation of inflamma-
tory molecules compared with healthy age- and sex-matched
controls (Gordon et al., 2018). These findings suggest that a
cell-intrinsic IFN-like response is activated in HGPS patients’
cells that contribute to cellular aging without an overt release
of inflammatory molecules that alert the immune system. Alter-
natively, progerin might activate inflammation locally, for
example in cells from the cardiovascular system, contributing
to atherosclerosis in patients.
In addition to the STAT1/IFN-like response identified here,
other studies showed an elevated NF-kB transcriptional profile
in cellular and mouse models of HGPS, which is linked to the
DNA damage response (Osorio et al., 2012). Inhibition of
NF-kB slows aging and increases longevity of progeria mice
and improves reprogramming of HGPS cells (Soria-Valles
et al., 2015). We propose amodel whereby RS and DNA damage
are sensed by cytoplasmic PRRs, including cGAS/STING
cytoplasmic DNA sensors, leading to activation of both NF-kB
and STAT1 pathways, which cooperate promoting cellular aging.
EXPERIMENTAL PROCEDURES
Cell Culture
Skin fibroblasts from four HGPS patients and three parents were obtained
from the Progeria Research Foundation (Supplemental Experimental Proced-
ures). MAFs were isolated from the ears of LmnaG609G/G609G and wild-type
mice and immortalized with SV40-LT. All cells were maintained in DMEM,
10% fetal bovine serum (FBS), antibiotics, and antimycotics. The Gonzalo
laboratory is approved for animal use.
Calcitriol Treatment
Cells were supplemented as described (Kreienkamp et al., 2016).
Other Treatments
Cells were treated for 10 days with ATRA (100 nM), remodelin (1 mM), or a
combination of lonafarnib (2 mM) and rapamycin (0.68 mM). Media with drugs
was replenished either daily (lonafarnib and rapamycin) or every 3 days
(ATRA, remodelin, calcitriol).
Progerin- and Lamin A-Inducible Cell Lines
HDFs containing doxycycline-inducible progerin or lamin A constructs were
treated as described (Kubben et al., 2016).
Immuno-FISH
Cells growing in coverslips were first processed for immunofluorescence with
anti-lamin A antibody, followed by processing for FISH. Cells were fixed in
3.7% paraformaldehyde/PBS for 10 min at room temperature (RT), washed
in PBS, dehydrated in ethanol (70%, 90%, 100% ethanol), and air-dried.
Hybridization solution containing the cy3-labeled telomeric probe was added
to coverslips, which were heated to 80C for 10 min and incubated for 3 hr at
RT. Coverslips were washed twice for 15 min in washing solution and three
times in PBS and stained with DAPI.
Viral Transduction
Retroviral and lentiviral transductions were performed as previously described
(Gonzalez-Suarez and Gonzalo, 2010). Viral envelope and packaging plasmids
were gifts from Sheila Stewart (Washington University School of Medicine
[WUSM]), progerin-expressing plasmid was a gift from Brian Kennedy (Buck
Institute), and shRNAs targeting STAT1 were purchased from Sigma-Aldrich.
Figure 3. Activation of PRRs, STAT1, and ISGs by Progerin
(A) Total cell lysates from BJs transduced with progerin or EV and processed for immunoblotting to detect lamin A (upper band) and progerin (lower band), DNA
damage (gH2AX), RS (P-RPA), PRRs (cGAS, STING, RIG-I, OAS1), and PRR effectors (STAT1, IRF3). Vinculin was used as loading control. Densitometry analysis
shown in Figure S1.
(B) HGPS fibroblasts were lentivirally transducedwith four independent shRNAs targeting STAT1 (shSTAT1) and shRNA control (shscr). After selection of infected
cells, levels of STAT1 protein were monitored by immunoblotting, and the levels of transcripts for STAT1 and STAT1-regulated ISGs (MX1, APOBEC3G, IFIT1) by
qRT-PCR. Graph shows average ± SEM of three or more independent experiments.
(C) HDFs were treated with doxycycline for increasing time periods (1–6 days). Fluorescence microscopy shows expression of GFP-progerin. Immunoblots show
levels of different lamin A forms: endogenous lamin A (lower band), GFP-lamin A (upper band), GFP-progerin (middle band), PRRs (cGAS, STING, MDA5, RIG-I),
STAT1 and P-STAT1 (Y701 and S727), ISG15, and progerin. b-Tubulin was used as loading control. Graph shows densitometry analysis in three ormore biological
repeats.
(D) RNA was extracted from progerin-expressing cells after 6 days in doxycycline, and the levels of total LMNA gene transcripts and transcripts of
STAT1-regulated ISGs (MX1, IFIT3, ISG15) were monitored by qRT-PCR. Graph shows average ± SEM of three independent experiments.
(E) MAFs were isolated from LmnaG609G/G609Gmice and wild-type (WT) littermates and immortalized with SV40-LT. Immunofluorescence with P-STAT1 antibody
shows increased nuclear STAT1 in G609G iMAFs compared with WT controls.
(F) iMAFs were processed for immunoblotting to monitor levels of gH2AX, STAT1, P-STAT1, and PRRs (MDA5, RIG-I). Graph shows mean densitometry analysis
of immunoblots (nR 2).
(G) BJ fibroblasts expressing progerin or EV and G609G and WT iMAFs were processed for immuno-FISH with a telomeric probe and lamin A antibody. The
percentage of cells with telomeric DNA outside the nucleus was quantitated.
* denotes p value of statistical significance (*p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001). Error bars represent SEM.
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Proliferation and Wound Closure Assays
BJ fibroblasts expressing progerin or not, and transduced with shSTAT1 or
shscr, were seeded on coverslips (3 3 105 cells/plate). Ki67 immunofluores-
cence was performed and images analyzed by counting the number of
Ki67-positive cells with respect to total nuclei stained with DAPI. The four
cell lines were also analyzed for migration in a wound closure assay. Cells
were seeded in 48-well plates, and after ON incubation the culture was
scratched with a sterile tip to produce a cell-free space (wound). Closure of
the space by cells (wound closure) was recorded taking snapshot pictures
at different time points (24–120 hr) and analyzing the cell-free area using
ImageJ software (NIH). The rate of closure of the wound is an indication of
cell migration.
Reprogramming
HGPS fibroblasts were treated with calcitriol or vehicle for 7 days. Cells
were then infected using the CytoTune-iPS 2.0 Sendai reprogramming kit,
which increased proliferation. After 7 days, 105 cells were seeded onto inacti-
vated MEF feeders and medium replaced with hES medium every day. Cells
were grown until hES-like colonies with a proper morphology emerged
(14 days). Colonies were stained with alkaline phosphatase and counted.
Statistical Analysis
For all qRT-PCR experiments, densitometry analysis, and reprogramming
experiments, a standard ‘‘two-tailed’’ Student’s t test was used to calculate
statistical significance of the observed differences. For DNA fiber experiments,
unpaired two-tailed t tests with Welch correction for unequal distribution were
performed. We used GraphPad Prism software for all statistical analyses. In all
cases, differences were considered statistically significant when p < 0.05.
Further details and an outline of resources used in this work can be found in
Supplemental Experimental Procedures.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq files reported in this paper is GEO:
GSE97986.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
one figure, and one table and can be found with this article online at https://
doi.org/10.1016/j.celrep.2018.01.090.
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Supplemental experimental procedures  
Immunoblotting and Immunofluorescence 
Immunoblotting. Cells were lysed in UREA buffer (8 M Urea, 40 mM Tris pH7.5, 1% NP40) for 20 
minutes on ice, and 60-120 μg of total protein was loaded on 4-15% Criterion-TGX-Gel (Bio-Rad). 
Subcellular fractionation was performed using a fractionation kit (Thermo, 78840). We started with 
an equal number of cells, and an equal volume of lysate was loaded for westerns. Densitometry 
analysis was performed using Image-J software. 
Immunofluorescence. 3x105 cells were fixed in 3.7% formaldehyde+0.2% Triton-X100 in PBS for 
10 minutes, washed 3X in PBS, and blocked 1 hour at 37°C in 10% BSA/PBS. Incubations with 
antibodies were performed for 1 hour at 37°C, in a humid chamber. After washes in PBS, cells 
were counterstained with DAPI in Vectashield. Microscopy and photo capture was performed on 
a Leica DM5000 B microscope using 40x or 63x oil objective lenses with a Leica DFC350FX 
digital camera and the Leica Application Suite.  
Quantitative Reverse-Transcription PCR 
cDNA was generated by reverse transcription of 1 μg total RNA using GeneAmp® RNA PCR 
kit. qRT-PCR was performed using the 7500HT Fast Real-Time PCR system with the Taqman® 
Universal PCR Master Mix or Universal SYBR Green Supermix. Reactions were carried out in 
triplicate and target gene and endogenous controls amplified in the same plate. Relative 
quantitative measurements of target genes were determined by comparing cycle thresholds. 
Table 3 in SI lists oligos used. 
DNA Fiber Assays 
Fiber assays were performed on retinal pigment epithelial cells (RPE cells) expressing EV or 
progerin. Asynchronous RPE cells were labeled for 25 min each with two thymidine analogs: 20 
μM iododeoxyuridine (ldU) followed by 200 μM chlorodeoxyuridine (CIdU). Cells were collected 
by trypsinization, washed and resuspended in 100 μl of PBS. Then, 2 μl cell suspension was 
dropped on a polarized slide (Denville Ultraclear) and cell lysis was performed in situ by adding 
8 μl of lysis buffer (200 mM Tris-HCl pH7.5; 50 mM EDTA; 0.5% SDS). Stretching of high-
molecular weight DNA was achieved by tilting the slides at 15-45°. The resulting DNA spreads 
were air dried and fixed for 5 min in 3:1 Methanol:Acetic acid, and refrigerated overnight. For 
immunostaining, stretched DNA fibers were denatured with 2.5 N HCl for 60 min, washed 3X in 
PBS, then blocked with 5% BSA in PBS for 30 min at 37oC. Rat anti-CldU/BrdU (Abcam, 
ab6326) (1:100), chicken anti-rat Alexa 488 (Invitrogen, A21470) (1:100), mouse anti-IdU/BrdU 
(BD Biosciences, 347580) (1:20) and goat anti-mouse IgG1 Alexa 547 (Invitrogen, A21123) 
(1:100) antibodies were used to reveal CldU- and IdU-labeled tracts, respectively. A Leica SP5X 
confocal microscope was used to visualize the labeled tracts, and tract lengths were measured 
using ImageJ (http://rsbweb.nih.gov.beckerproxy.wustl.edu/ij/). Statistical analysis of the tract 
length was performed using GraphPad Prism (http://www.graphpad.com/scientific-
software/prism/). 
RNAseq 
Normal and HGPS fibroblasts supplemented with 10-7 M calcitriol (1α,25-dihydroxyvitamin D3; 
Sigma-Aldrich) or FBS for different periods of time (NF for 4 days and HGPS for 4 and 90 days) 
were utilized to extract total RNA using Aurum Total RNA Mini Kit (Bio-Rad) with DNaseI 
treatment following the manufacturer’s protocol. Ribosomal RNA depletion was performed with 
500 ng of total RNA with the Ribominus Eukaryotic System v2 (Life Technologies) according to 
the manufacturer’s directions. The rRNA-depleted RNA was used to construct barcoded 
libraries using the Ion Total RNA-Seq Kit v2 (Life Technologies), following the manufacturer’s 
instructions. The libraries were sequenced on an Ion Torrent Proton with a mean read length of 
~100 nucleotides.  
RNA-seq quantification was performed using a method similar to that described previously 1. 
Sequencing reads were aligned to the hg19 genome sequence using the map4 algorithm in the 
TMAP aligner (https://github.com/iontorrent/TMAP/blob/master/doc/tmap-book.pdf), allowing 
soft clipping of both the 5’ and 3’ ends (option -g 0) and a minimum seed length of 20. The 
resulting bam files were sorted using SAMtools 2 and used to generate strand-specific bedgraph 
files of the base pair coverage using BEDTools 3. A custom R (R Core Team; http://www.R-
project.org) script was used to convert the strand-specific bedgraph files to sgr files, which were 
used to sum the strand-specific base pair coverage of non-redundant sets of plus strand and 
minus strand exons using a custom R script. The nucleotide coverage values of all exons for 
each gene were summed using an R script to generate nucleotide coverage values for all 
annotated genes. The coverage values for each gene were normalized to the total coverage for 
all genes for each library to allow quantitative comparisons. 
All RNA-seq files were submitted to the GEO repository, and the following accession number 
was assigned: GSE97986.  
Gene Ontology analysis and heat-map generation 
DAVID (http://david.niaid.nih.gov) bioinformatics resource was used to obtain functional 
interpretation of gene expression changes in HGPS compared to NF and in HGPS treated with 
calcitriol versus vehicle. We uploaded gene lists and via functional annotation clustering, we 
obtained gene-term enrichment analysis and biological mechanisms associated with the gene 
lists. We used gene-enrichment scores to generate heat-maps in order to represent biological 
data. Heat-maps were generated using a custom R script using the g-plots package. Values 
represent log2 values of relative gene expression as determined by RNA sequencing. 
Resource Table 
 
Cells (Skin fibroblasts) from 
Progeria Research Foundation Description 
HGPS2-HGADFN167 Fibroblasts from HGPS patient with classic mutation 
HGADFN003 Fibroblasts from HGPS patient with classic mutation 
HGPS3-PSADFN392 Fibroblasts from HGPS patient with non-classic mutation 
PSADFN257 Fibroblasts from HGPS patient with non-classic mutation 
PSFDFN327 Fibroblasts from parent of HGPS patient  
HGMDFN090 Fibroblasts from parent of HGPS patient 
PSMDFN346 Fibroblasts from parent of HGPS patient 
Antibodies used for 
immunoblotting Antibody (Dilution) 
gH2AX #2577, Cell Signaling (1:1000) 
53BP1 sc-22760, SCBT (1:1000) 
Lamin A ab26300, Abcam (1:1000) 
Progerin SAB4200272, Sigma-Aldrich (1:1000) 
Lamin A/C sc-20681, SCBT (1:2000) 
Vinculin sc-7649, SCBT (1:1000) 
VDR sc-13133, SCBT (1:200) 
β-Tubulin T8238, Sigma Aldrich (1:2000) 
STAT #9172, Cell Signaling (1:1000) 
P-STAT (Y701) #7649, Cell Signaling (1:1000) 
P-STAT (S727) #9177, Cell Signaling (1:1000) 
IRF3 #11904, Cell Signaling (1:1000) 
P-RPA A300-245A, Bethyl Laboratories (1:1000) 
RPA NA18, EMD Millipore (1:1000) 
ISG15 sc-166755, SCBT (1:1000) 
MDA5 #5321, Cell Signaling (1:1000) 
RIG-I #3743, Cell Signaling (1:1000) 
cGAS #D1D3G, Cell Signaling (1:300) 
STING #D2P2F, Cell Signaling (1:1000) 
 
Antibodies used for immunofluorescence Antibody 
gH2AX #2577, Cell Signaling  
Lamin A ab26300, Abcam  
STAT #9172, Cell Signaling  
P-STAT (Y701) #7649, Cell Signaling  
P-STAT (S727) #9177, Cell Signaling  
Goat anti-Mouse and Goat anti-Rabbit Alexa 
Fluor 594/488-labeled secondary antibodies 
Invitrogen 
 
Primers used for SYBR Green 
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Figure S1. Related to Figure 3A; Replication stress and activation of STAT1 pathway upon 
progerin expression in normal cells. Total cell lysates from BJ fibroblasts expressing progerin
or EV control were processed for immunoblotting and densitometry analysis performed in three 
biological repeats. Note the increased levels of DNA damage (gH2AX), replication stress (P-
RPA), and STAT1 phosphorylation in progerin-expressing cells. 
